Search

Search Constraints

You searched for: Author/Creator Lusivika-Nzinga, Clovis

Search Results

1. Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study. (19th July 2021)

2. Corrigendum to: Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study. (28th August 2021)

3. Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S COCOPREV study). Issue 6 (June 2022)

4. Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2. Issue 4 (October 2022)

5. Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvir. (April 2023)